[Proposal of anticoagulant strategies in continuous renal replacement therapy].

Anticoagulant therapy is an important component of continuous renal replacement therapy (CRRT). This article is based on evidence-based medicine and systematically summarizes the status and issues of anticoagulant regimens such as unfractionated heparin, regional heparinization, low molecular weight heparin, regional citrate anticoagulation, agatroban, nafamostat mesylate, and prostacyclin during CRRT in patients with or without high-risk bleeding, heparin induced thrombocytopenia or liver dysfunction, and provides recommendations, aiming to guide clinicians in the rational selection of anticoagulant regimens for CRRT.